However, additional studies with multiple chordoma cell lines or primary chordoma organoids are needed to investigate all possible fates of chordoma cells after TBXT inhibition and to develop biomarkers of differentiation for guiding future TBXT-targeted therapies. Here, TBXT is linked to chordoma.